Axogen (AXGN) EBIT (2010 - 2026)
Axogen's (AXGN) quarterly EBIT came in at -$2.8 million in Q1 2026, down 70.5% year-on-year from -$9.6 million in Q1 2025, and up 71.02% quarter-over-quarter from -$9.8 million in Q4 2025.
Axogen (AXGN) EBIT (2010 - 2026) Analysis & Trends
Axogen's EBIT history runs 17 years deep, the most recent figure standing at -$2.8 million for Q1 2026.
- On a quarterly basis, EBIT fell 70.5% year-over-year to -$2.8 million in Q1 2026; TTM through Mar 2026 was -$9.0 million, a 2224.74% decrease from a year earlier, with the FY2025 full-year figure at -$7.8 million, down 138.79% from the prior year.
- EBIT improved to -$2.8 million in Q1 2026 per AXGN's latest filing, from -$9.8 million in the prior quarter.
- Across five years, EBIT topped out at $2.0 million in Q4 2024 and bottomed at -$11.3 million in Q1 2022.
- The 5-year median for EBIT is -$4.0 million (2023), against an average of -$3.8 million.
- Biggest YoY gain for EBIT was 705.06% in 2025; the steepest drop was 584.48% in 2025.
- Year by year, EBIT stood at -$5.6 million in 2022, then jumped by 43.05% to -$3.2 million in 2023, then surged by 163.15% to $2.0 million in 2024, then slumped by 584.48% to -$9.8 million in 2025, then soared by 71.02% to -$2.8 million in 2026.
- Per Business Quant, the three latest AXGN EBIT figures stand at -$2.8 million (Q1 2026), -$9.8 million (Q4 2025), and $1.9 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | -2.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.83 Mn |
| Dec 31, 2025 | -9.77 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | -1.66 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | -316,000.00 |
| Jun 30, 2024 | -428,000.00 |
| Mar 31, 2024 | -4.56 Mn |
| Dec 31, 2023 | -3.19 Mn |
| Sep 30, 2023 | -4.03 Mn |
| Jun 30, 2023 | -6.90 Mn |
| Mar 31, 2023 | -7.34 Mn |
| Dec 31, 2022 | -5.61 Mn |
| Sep 30, 2022 | -4.86 Mn |
| Jun 30, 2022 | -7.92 Mn |
| Mar 31, 2022 | -11.32 Mn |
| Dec 31, 2021 | -5.35 Mn |
| Sep 30, 2021 | -6.69 Mn |
| Jun 30, 2021 | -7.15 Mn |